A new anti-cancer drug in the market: Good news for investors or for patients?

Eur J Cancer. 2008 Sep;44(13):1786-8. doi: 10.1016/j.ejca.2008.06.021. Epub 2008 Jul 30.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / economics*
  • Drug Approval
  • Drug Costs
  • Drug Industry
  • Humans
  • Investments

Substances

  • Antineoplastic Agents